Dr Benjamin Jonah Delprete, DO | |
2150 Pennsylvania Ave Nw, Washington, DC 20037-3201 | |
(202) 741-3000 | |
Not Available |
Full Name | Dr Benjamin Jonah Delprete |
---|---|
Gender | Male |
Speciality | Student In An Organized Health Care Education/training Program |
Location | 2150 Pennsylvania Ave Nw, Washington, District Of Columbia |
Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1073019139 | NPI | - | NPPES |
Mailing Address | Practice Location Address |
---|---|
Dr Benjamin Jonah Delprete, DO 2150 Pennsylvania Ave Nw, Washington, DC 20037-3201 Ph: (202) 741-3000 | Dr Benjamin Jonah Delprete, DO 2150 Pennsylvania Ave Nw, Washington, DC 20037-3201 Ph: (202) 741-3000 |
News Archive
The wide range of manifestations of COVID-19 has continued to baffle investigators. Now, a new study published on the preprint server medRxiv in June 2020 shows that blood proteins in COVID-19 patients change over time, and these can possibly predict or reflect the severity of disease. More, they may present targets for treatment.
Vitamin C administration shortened the length of stay in the intensive care unit on average by 8% in 12 trials with 1766 patients according to a meta-analysis published in Nutrients.
A new study tells us more about what presses the trigger when it comes to harsh parenting by alcohol-dependent mothers.
Biogen Idec and Biovitrum AB (STO: BVT) today announced that they plan to advance the companies' long-acting, fully-recombinant Factor IX Fc fusion protein (rFIXFc) into a registrational clinical trial in hemophilia B patients.
› Verified 7 days ago